• Latest
  • Trending
  • All
  • Egypt
  • Business
  • Local
  • World
US approves 1st vaccine for RSV after decades of attempts

US approves 1st vaccine for RSV after decades of attempts

May 5, 2023
Egypt steps up efforts to deepen mobile phone manufacturing

Egypt steps up efforts to deepen mobile phone manufacturing

November 22, 2026
Egypt says irregular migration to Europe fell 67 per cent

Egypt condemns attacks targeting Bahrain

November 22, 2026
Egypt seeks stronger African partnerships to promote regional security, stability

Egypt seeks stronger African partnerships to promote regional security, stability

November 22, 2026
COP31 fails to reach climate deal

COP31 fails to reach climate deal

November 22, 2026
Egypt seeks to become regional auto manufacturing hub

Egypt seeks to become regional auto manufacturing hub

November 22, 2026
Egypt sets out roadmap for lasting Middle East peace

Egypt sets out roadmap for lasting Middle East peace

November 22, 2026
Lebanon army seizes 264 kg explosives, arrests 3

Lebanon army seizes 264 kg explosives, arrests 3

November 22, 2026
Egypt’s economy grows 4.9 per cent in first quarter of FY2026/27

Egypt’s economy grows 4.9 per cent in first quarter of FY2026/27

November 22, 2026
PM Madbouly urges more private investment in renewable energy

PM Madbouly urges more private investment in renewable energy

November 22, 2026
South Korea education chief resigns over AI

South Korea education chief resigns over AI

November 22, 2026
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, November 22, 2026
  • Login

Editor-in-Chief

Mohamed Fahmy

Board Chairman

Tarek Lotfy

Egyptian Gazette
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
No Result
View All Result
Egyptian Gazette
Home Entertainment Health

US approves 1st vaccine for RSV after decades of attempts

by News Wires
May 5, 2023
in Health
GSK's Arexvy approval covers adults 60 and older in the US.

GSK's Arexvy approval covers adults 60 and older in the US.

Share on FacebookWhatsapp

WASHINGTON – The US approved the first vaccine for RSV, shots to protect older adults against a respiratory virus that´s most notorious for attacking babies but endangers their grandparents, too.

The Food and Drug Administration decision makes GSK´s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.

The vaccine, Arexvy, was approved for people aged 60 and older, the company said.

The move sets the stage for adults 60 and older to get vaccinated this fall – but first, the Centers for Disease Control and Prevention must decide if every senior really needs RSV protection or only those considered at high risk from the respiratory syncytial virus. CDC´s advisers will debate that question in June.

The approval makes GSK, which has been neck-and-neck with Pfizer in RSV vaccine development, the first company to tap into a multi-billion-dollar market and also puts it ahead of rivals such as Moderna Inc and Bavarian Nordic.

Analysts have estimated the market for RSV vaccines to surpass $10 billion by 2030. Credit Suisse analysts expect $2.5 billion in peak sales for GSK’s RSV vaccine for older adults.

GSK expects the vaccine to be available before the next RSV season in the United States, Chief Commercial Officer Luke Miels told Reuters, ahead of the approval.

He said the vaccine would be priced above $120 per shot provided the data from a study, which is expected soon, shows that it offers protection for two RSV seasons.

RSV cases in the most recent season started last year in June and peaked in November, the US Centers for Disease Control and Prevention (CDC) said.

The question on how often the vaccine should be given is to be placed before CDC’s panel of advisors on immunisation. The panel is scheduled to meet in June and the agenda was not immediately clear.

The CDC did not immediately respond to a Reuters request for comment.

RSV is responsible for 14,000 deaths in adults aged 65 and older annually in the United States, according to government estimates.

GSK’s vaccine showed overall efficacy of 82.6 per cent and was about 94 per cent effective against severe lower respiratory tract disease associated with an RSV infection among participants aged 60 and older in its late-stage trial.

Tags: ArexvyHealthRSVUSA

Discussion about this post

ADVERTISEMENT
egyptian-gazette-logo

The Egyptian Gazette is the oldest English-language daily newspaper in the Middle East.
It was first published on January 26, 1880 and it is part of El Tahrir Printing and Publishing House.

Follow Us

Egypt steps up efforts to deepen mobile phone manufacturing

Egypt condemns attacks targeting Bahrain

Egypt seeks stronger African partnerships to promote regional security, stability

COP31 fails to reach climate deal

Egypt seeks to become regional auto manufacturing hub

  • Advertise
  • Privacy & Policy
  • Contact

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.